Thanks for weighing in. The difference between your forecasts and mine is tantamount to round-off error. For all practical purposes, you, ‘dewophile’, and I are in agreement regarding the pricing dynamics in the US HCV market.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”